Corindus Vascular Robotics Appoints Campbell Rogers, M.D. To Its Board Of Directors

WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS) today announced that Campbell Rogers, M.D. has been appointed to its Board of Directors, effective immediately.

Dr. Rogers is a veteran in the medical technology industry and healthcare field with over 30 years of experience in commercialization, development, education and research. Since 2012, Dr. Rogers has served as Chief Medical Officer of HeartFlow, Inc., a cardiovascular diagnostics company providing the first available non-invasive solution that enables physicians to more accurately evaluate significant coronary artery disease based on both anatomy and physiology.

MORE ON THIS TOPIC